Profil
Alan F.
Wahl worked as a Senior Director at Abbott Laboratories from 2011 to 2013.
Prior to that, he was a Director at Seagen Inc. from 1998 to 2006.
He also served as Vice President of Research and Discovery at Ambrx, Inc. Dr. Wahl holds a graduate degree and a doctorate from the University of Rochester and an undergraduate degree from Rochester Institute of Technology.
Anciens postes connus de Alan F. Wahl
| Sociétés | Poste | Fin |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/12/2013 |
| SEAGEN INC. | Corporate Officer/Principal | 01/05/2006 |
| AMBRX INC | Directeur Technique/Scientifique/R&D | - |
Formation de Alan F. Wahl
| Rochester Christian University | Doctorate Degree |
| Rochester Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Entreprise privées | 2 |
|---|---|
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
